Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Goetz

Showing results (141-150 of 397) with videos related to

Pageof 40
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2013
Reply to A.-S. Dieudonné et al and J.M. Rae et alHiltrud Brauch, Werner Schroth, Matthew P Goetz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2012
Tamoxifen use in postmenopausal breast cancer: CYP2D6 mattersHiltrud Brauch, Werner Schroth, Matthew P Goetz, et al.
Genes, Chromosomes & Cancer|July 21, 1998
Allele loss in Wilms tumors of chromosome arms 11q, 16q, and 22q correlate with clinicopathological parametersB Klamt, M Schulze, C Thäte, et al.
Genetika|August 6, 2005
Fluorescent multiplex PCR--fast method for autosomal dominant spinocerebellar ataxias screeningP O Bauer, S E Kotliarova, V Matoska, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 9, 2022
Bioavailability and Pharmacokinetics of Endoxifen in Female Rats and Dogs: Evidence to Support the Use of Endoxifen to Overcome the Limitations of CYP2D6-Mediated Tamoxifen MetabolismEmily J Koubek, Sarah A Buhrow, Stephanie L Safgren, et al.
Menopause (New York, N.Y.)|May 21, 2020
Baseline estrogen levels in postmenopausal women participating in the MAP.3 breast cancer chemoprevention trialHarriet Richardson, Vikki Ho, Romain Pasquet, et al.
Breast Cancer (Tokyo, Japan)|October 18, 2021
Japanese subgroup analysis of the phase 3 MONARCH 3 study of abemaciclib as initial therapy for patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancerMasato Takahashi, Eriko Tokunaga, Joji Mori, et al.
Breast Cancer Research : BCR|March 20, 2025
Evaluation of the androgen receptor in patients with ERα-positive early breast cancer treated with adjuvant tamoxifen ± fluoxymesteroneJames N Ingle, Vera J Suman, Malvika H Solanki, et al.
Academic Radiology|November 8, 2020
MRI Radiomics for Assessment of Molecular Subtype, Pathological Complete Response, and Residual Cancer Burden in Breast Cancer Patients Treated With Neoadjuvant ChemotherapySadia Choudhery, Daniel Gomez-Cardona, Christopher P Favazza, et al.
Nature Communications|March 26, 2021
A general approach to high-efficiency perovskite solar cells by any antisolventAlexander D Taylor, Qing Sun, Katelyn P Goetz, et al.
Pageof 40

Showing results (141-150 of 397) with videos related to

Sort By:
Pageof 40
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2013
Reply to A.-S. Dieudonné et al and J.M. Rae et alHiltrud Brauch, Werner Schroth, Matthew P Goetz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2012
Tamoxifen use in postmenopausal breast cancer: CYP2D6 mattersHiltrud Brauch, Werner Schroth, Matthew P Goetz, et al.
Genes, Chromosomes & Cancer|July 21, 1998
Allele loss in Wilms tumors of chromosome arms 11q, 16q, and 22q correlate with clinicopathological parametersB Klamt, M Schulze, C Thäte, et al.
Genetika|August 6, 2005
Fluorescent multiplex PCR--fast method for autosomal dominant spinocerebellar ataxias screeningP O Bauer, S E Kotliarova, V Matoska, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 9, 2022
Bioavailability and Pharmacokinetics of Endoxifen in Female Rats and Dogs: Evidence to Support the Use of Endoxifen to Overcome the Limitations of CYP2D6-Mediated Tamoxifen MetabolismEmily J Koubek, Sarah A Buhrow, Stephanie L Safgren, et al.
Menopause (New York, N.Y.)|May 21, 2020
Baseline estrogen levels in postmenopausal women participating in the MAP.3 breast cancer chemoprevention trialHarriet Richardson, Vikki Ho, Romain Pasquet, et al.
Breast Cancer (Tokyo, Japan)|October 18, 2021
Japanese subgroup analysis of the phase 3 MONARCH 3 study of abemaciclib as initial therapy for patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancerMasato Takahashi, Eriko Tokunaga, Joji Mori, et al.
Breast Cancer Research : BCR|March 20, 2025
Evaluation of the androgen receptor in patients with ERα-positive early breast cancer treated with adjuvant tamoxifen ± fluoxymesteroneJames N Ingle, Vera J Suman, Malvika H Solanki, et al.
Academic Radiology|November 8, 2020
MRI Radiomics for Assessment of Molecular Subtype, Pathological Complete Response, and Residual Cancer Burden in Breast Cancer Patients Treated With Neoadjuvant ChemotherapySadia Choudhery, Daniel Gomez-Cardona, Christopher P Favazza, et al.
Nature Communications|March 26, 2021
A general approach to high-efficiency perovskite solar cells by any antisolventAlexander D Taylor, Qing Sun, Katelyn P Goetz, et al.
Pageof 40